Advertisement
Bio-Techne Corporation

Bio-Techne Corporation (TECH) Stock Overview

Explore Bio-Techne Corporation’s financial performance, market position, analyst ratings, and future outlook.

TECHNASDAQ
HealthcareBiotechnology
$71.48
$0.25(0.35%)
U.S. Market opens in 16h 12m
Advertisement

Bio-Techne Corporation (TECH)

Meyka AI Score

Z

Key Financials

Market Cap11.2B
P/E Ratio100.35
EPS (TTM)$1.94
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Month$74.76
3 Months$71.64
1 Year Target$55.67

TECH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bio-Techne Corporation (TECH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 76.18, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $55.67.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 100.35 and a market capitalization of 11.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.35%
5-Day Change
0.58%
1-Month Change
27.26%
3-Month Change
22.21%
6-Month Change
2.17%
Year-to-Date (YTD) Change
21.54%
1-Year Change
39.01%
3-Year Change
-13.67%
5-Year Change
-36.39%
All-Time (Max) Change
65250.16%

Contact Information

612 379 8854
614 McKinley Place N.E., Minneapolis, MN, 55413

Company Facts

31,000 Employees
IPO DateFeb 9, 1989
CountryUS
Actively Trading

Frequently Asked Questions